Patients with soft tissue sarcoma experienced a confirmed clinical response following treatment with a targeted therapy, according to a recent study. READ MORE

Conferences

Health-related quality of life and its impact on disease progression should be a consideration when selecting treatment for sarcoma.

READ MORE

News

Patients with soft tissue sarcoma experienced a confirmed clinical response following treatment with a targeted therapy, according to a recent study.

READ MORE

The best potential strategy involving tyrosine kinase inhibitors for the treatment of gastrointestinal stromal tumors has been identified.

READ MORE

Kaposi Sarcoma (KS) skin lesions are more likely to respond to local external beam radiotherapy than repeat radiotherapy.

READ MORE

Research in Review

Tivozanib was well-tolerated and showed promising antitumor activity in patients with soft tissue sarcoma overexpressing vascular endothelial growth factors, supporting efforts for further research.

READ MORE

Neoadjuvant chemotherapy with epirubicin plus ifosfamide improves outcomes in patients with soft tissue sarcoma who are at high-risk of recurrence.

READ MORE

Results argue against the inclusion of ifosfamide and etoposide to postoperative chemotherapy in patients with poorly responding osteosarcoma.

READ MORE